Zebra Technologies enters the week after a blowout earnings day with two stories pulling in opposite directions: the Street is raising targets and short sellers are building positions at the fastest pace in months.
The earnings reaction was stark. The stock jumped 11.4% on May 12, landing at $241.79. That follows a 5.9% gain on the week and an 8.9% rise over the past month. Zebra reported Q1 revenues of $1.48 billion — up 10.6% year-on-year and above guidance. Yet despite the rally, the stock remains down about 11% year-to-date, which helps explain why shorts haven't rushed for the exit.
Short interest has climbed sharply in the weeks around the print. SI as a percentage of free float now runs at 6.8% — up from 5.1% one week ago and 4.6% a month ago. That's a 35% increase in one week alone. The ORTEX short score has jumped from the low 40s in late April to 46.1 today, its highest reading in the tracked period. Borrow availability remains relaxed — the lending market is not under any stress, with cost to borrow at just 0.53% and availability broadly comfortable. The picture is one of deliberate short-building rather than a crowded squeeze setup. Options positioning echoes that balance: the put/call ratio of 0.60 is fractionally below its 20-day average of 0.64, with a z-score barely in negative territory. Neither bulls nor bears are pressing an options view with conviction.
The analyst community delivered an unusually coordinated response to the earnings beat. Six firms moved their targets higher on May 13 alone. Barclays lifted its Overweight target to $345 from $330. Baird raised its Outperform target to $310 from $300. Needham reiterated Buy at $345. Notably, Keybanc upgraded the stock outright — to Overweight from Sector Weight — with a $305 target. The neutrals edged up too: Citigroup raised its Neutral target to $284, and Truist Securities lifted its Hold target to $267. The consensus sits at 10 Buy and 4 Hold recommendations, with a mean price target of $328 — implying roughly 36% upside from current levels. That's a wide gap, reflecting both how far the stock has fallen from its prior highs and the genuine optimism on the bull side about the automation cycle. The bull case centres on accelerating demand for data capture and enterprise mobility solutions, plus raised 2026 non-GAAP EPS guidance toward $18. Bears point to flat gross margins at 48.2%, a 50-basis-point year-on-year decline, an organic sales contraction in EMEA, and a $6 million tariff headwind to gross profit.
The insider picture adds a mildly cautious note. On May 4, at least nine executives filed sales at $223.73 per share — including CEO William Burns, who sold 6,185 shares for approximately $1.4 million, and CFO Nathan Winters, who sold 2,663 shares for roughly $596,000. The trades were all at prices well below Tuesday's close of $241.79, suggesting they were pre-planned rather than opportunistic. Over the 90-day window the net insider position is a modest positive at around 32,000 shares, so this is not a broad exodus — but the cluster of simultaneous C-suite sells ahead of the earnings pop will attract attention.
The closest peers offer a useful contrast. CGNX and IPGP both rallied hard on the week — up 11.6% and 13.0% respectively — suggesting a broader bid for industrial technology names. VNT was the notable laggard, falling 16% on the week. ZBRA's 5.9% weekly gain looks measured against that backdrop. Given next earnings is flagged for May 19, the more pressing question is whether the short-building of the past two weeks reflects new fundamental doubts or simply hedging ahead of a catalyst that has now partly cleared.
What to watch: whether the surge in short interest — up 45% over the past month — continues to build even as analysts raise targets, and whether the gap between the $241 current price and the $328 consensus mean narrows or stays wide ahead of the next scheduled event.
See the live data behind this article on ORTEX.
Open ZBRA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
